Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients
Takeshi Ishikawa, Shinichi Kageyama, Yoshihiro Miyahara, Tetsuya Okayama, Satoshi Kokura, Linan Wang, Eiichi Sato, Hideo Yagita∥, Yoshito Itoh, Hiroshi Shiku
Topics & Concepts
Immune systemMedicineAdjuvantCancerAntibodyAdverse effectCD8ImmunologyAntibody titerInternal medicineClinical endpointGastroenterologyClinical trialTiterImmunotherapy and Immune Responsesvaccines and immunoinformatics approachesGlycosylation and Glycoproteins Research